[go: up one dir, main page]

DE69637449D1 - Verwendung von alpha-hydroxysäuren zur herstellung eines arzneimittels für die behandlung von entzündungen - Google Patents

Verwendung von alpha-hydroxysäuren zur herstellung eines arzneimittels für die behandlung von entzündungen

Info

Publication number
DE69637449D1
DE69637449D1 DE69637449T DE69637449T DE69637449D1 DE 69637449 D1 DE69637449 D1 DE 69637449D1 DE 69637449 T DE69637449 T DE 69637449T DE 69637449 T DE69637449 T DE 69637449T DE 69637449 D1 DE69637449 D1 DE 69637449D1
Authority
DE
Germany
Prior art keywords
inflammation
medicament
preparation
treatment
hydroxylic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69637449T
Other languages
English (en)
Other versions
DE69637449T2 (de
Inventor
Hakon Westermarck
Pentti Hietala
Maire Jaarma
Timo Sorsa
Martti Vaara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OSAKEYHTIOE EXTRACTA Ltd
Original Assignee
OSAKEYHTIOE EXTRACTA Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI953090A external-priority patent/FI953090A0/fi
Application filed by OSAKEYHTIOE EXTRACTA Ltd filed Critical OSAKEYHTIOE EXTRACTA Ltd
Publication of DE69637449D1 publication Critical patent/DE69637449D1/de
Application granted granted Critical
Publication of DE69637449T2 publication Critical patent/DE69637449T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69637449T 1995-06-21 1996-06-20 Verwendung von alpha-hydroxysäuren zur herstellung eines arzneimittels für die behandlung von entzündungen Expired - Lifetime DE69637449T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FI953090 1995-06-21
FI953090A FI953090A0 (fi) 1995-06-21 1995-06-21 Foerfarande foer framstaellning av alfahydroxidsyra eller en produkt som innehaoller den, och dess onvaendning samt vaordmetod
FI962602A FI119543B (fi) 1995-06-21 1996-06-20 Alfa-hydroksihappojen käyttö valmistettaessa lääkettä tulehduksen hoitoon
FI962602 1996-06-20
PCT/FI1996/000363 WO1997000676A1 (en) 1995-06-21 1996-06-20 Antimicrobial and anti-inflammatory compounds

Publications (2)

Publication Number Publication Date
DE69637449D1 true DE69637449D1 (de) 2008-04-10
DE69637449T2 DE69637449T2 (de) 2009-03-12

Family

ID=26159986

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69637449T Expired - Lifetime DE69637449T2 (de) 1995-06-21 1996-06-20 Verwendung von alpha-hydroxysäuren zur herstellung eines arzneimittels für die behandlung von entzündungen

Country Status (6)

Country Link
EP (1) EP0871438B1 (de)
AU (1) AU6225896A (de)
DE (1) DE69637449T2 (de)
DK (1) DK0871438T3 (de)
FI (1) FI119543B (de)
WO (1) WO1997000676A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190675B1 (en) 1997-06-04 2001-02-20 Procter & Gamble Company Mild, rinse-off antimicrobial liquid cleansing compositions which provide improved residual benefit versus gram positive bacteria
US6210695B1 (en) 1997-06-04 2001-04-03 The Procter & Gamble Company Leave-on antimicrobial compositions
US6197315B1 (en) 1997-06-04 2001-03-06 Procter & Gamble Company Antimicrobial wipes which provide improved residual benefit versus gram negative bacteria
US6190674B1 (en) 1997-06-04 2001-02-20 Procter & Gamble Company Liquid antimicrobial cleansing compositions
US6284259B1 (en) 1997-11-12 2001-09-04 The Procter & Gamble Company Antimicrobial wipes which provide improved residual benefit versus Gram positive bacteria
US6183763B1 (en) 1997-06-04 2001-02-06 Procter & Gamble Company Antimicrobial wipes which provide improved immediate germ reduction
US6214363B1 (en) 1997-11-12 2001-04-10 The Procter & Gamble Company Liquid antimicrobial cleansing compositions which provide residual benefit versus gram negative bacteria
US5968539A (en) * 1997-06-04 1999-10-19 Procter & Gamble Company Mild, rinse-off antimicrobial liquid cleansing compositions which provide residual benefit versus gram negative bacteria
US6183757B1 (en) 1997-06-04 2001-02-06 Procter & Gamble Company Mild, rinse-off antimicrobial cleansing compositions which provide improved immediate germ reduction during washing
US6287577B1 (en) 1997-11-12 2001-09-11 The Procter & Gamble Company Leave-on antimicrobial compositions which provide improved residual benefit versus gram positive bacteria
US6287583B1 (en) 1997-11-12 2001-09-11 The Procter & Gamble Company Low-pH, acid-containing personal care compositions which exhibit reduced sting
FR2810547B1 (fr) * 2000-06-22 2004-01-30 Pasteur Institut Utilisation d'acides en c2-c10 pour la prevention des infections a bacteries a gram negatif
FR2863168A1 (fr) * 2003-12-04 2005-06-10 Centre Nat Rech Scient Utilisation d'inducteurs de la voie de degradation de la gamma-butyrolactone pour inactiver le signal n-acy homoserine lactone.
US20220218761A1 (en) * 2019-05-06 2022-07-14 The General Hospital Corporation Monitoring and altering the gut microbiome in disease
FI129515B (en) 2020-11-06 2022-03-31 Salarusta Oy FOR USE IN THE PREVENTION AND / OR TREATMENT OF A DISEASE OR CONDITION RELATED TO THE DEGRADATION AND / OR DISTURBANCE OF THE DEGREE OF MONTOOSASE AND / OR INTEGRITY
CN117919216A (zh) * 2024-01-29 2024-04-26 中国药科大学 2-羟基-3-甲基丁酸在制备预防和/或治疗动脉粥样硬化的药物中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU618517B2 (en) * 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents

Also Published As

Publication number Publication date
FI962602L (fi) 1996-12-22
FI119543B (fi) 2008-12-31
AU6225896A (en) 1997-01-22
EP0871438B1 (de) 2008-02-27
WO1997000676A1 (en) 1997-01-09
DK0871438T3 (da) 2008-06-30
FI962602A0 (fi) 1996-06-20
EP0871438A1 (de) 1998-10-21
DE69637449T2 (de) 2009-03-12

Similar Documents

Publication Publication Date Title
ATE252901T1 (de) Arzneimittel zur behandlung von entzündlichen herzkrankheiten
ATE195527T1 (de) Neue steroidester zur behandlung von hauterkrankungen
DE69637449D1 (de) Verwendung von alpha-hydroxysäuren zur herstellung eines arzneimittels für die behandlung von entzündungen
DE122005000002I1 (de) Verwendung von Venlafaxin oder eines Aryloxy-Propanaminderivates zur Herstellung eines Medikaments zur Behandlung von Inkontinenz.
DE59608738D1 (de) Verwendung von epinastin für die behandlung von schmerzen
DE69509544D1 (de) Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten
FI952721A7 (fi) Aine maksa-sappi-sairauksien hoitamiseksi
DE69619753D1 (de) Verwendung mindestens eines die Tripeptidsequenz Lys-DPro-Arg enthaltenden Peptids zur Herstellung eines Arzneimittels zur Behandlung einer Entzündung
DE69934813D1 (de) Verwendung von gaba analogen zur herstellung eines arzneimittels zur behandlung von manie und bipolaren erkrankungen
DE69010251D1 (de) Dentale Einheit zur Behandlung eines Wurzelkanals.
DE69635298D1 (de) Verwendung von Acetylsalicylsäuren zur Herstellung eines Medikaments für die Behandlung von Hautverletzungen
ATE269077T1 (de) Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen
DE68924714D1 (de) Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen.
DE69925488D1 (de) Verwendung von fk506 und verwandten makroliden zur herstellung eines medikaments für die behandlung und vorbeugung von schmerzen
DE3583220D1 (de) Verwendung von dipeptidderivaten fuer die herstellung von arzneimitteln zur behandlung von an amyotropher lateralsklerose erkrankten.
ATE221763T1 (de) Die verwendung von glyceryltriacetat zur behandlung von onychomykosen
ATE246518T1 (de) Egr-1 zur herstellung eines medikamentes zur behandlung von wunden
DE69423577D1 (de) Verwendung von Oenothein B zur Herstellung eines Medikaments zur Behandlung der durch Hyperandrogenität bedingte Störungen.
DE69232911D1 (de) Verwendung eines polyhydroxybenzamids oder dessen Derivat zur Herstellung eines Medikaments für die Behandlung von viralen Infektionen
DE69313261D1 (de) Verwendung von LACTOFERRIN zur Herstellung eines THERAPEUTISCHEN MITTELS zur Behandlung von RHEUMATISMUS
DE69003960D1 (de) Die Verwendung von deacetyliertem Chitin zur Herstellung eines Medikamentes für die Behandlung von entzündliche Krankheiten.
DE69515666D1 (de) VERWENDUNG VON GnRH-ANTAGONISTEN ZUR HERSTELLUNG EINES MEDIKAMENTS ZUR BEHANDLUNG GONADEN-STEROID ABHÄNGIGER ERKRANKUNGEN
DE69620786D1 (de) Verwendung von cholinesterase-inhibitoren für die herstellung eines medikaments zur behandlung von xerostomie
DE69632677D1 (de) Verwendung eines Rifamycin-Derivates zur Herstellung eines Medikamentes zur Behandlung von Krankheiten verursacht durch Helicobacter pylori-Infektionen
DE69739190D1 (de) Arzneimittel zur behandlung von oculären kreislauferkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition